Luxembourg
M&As this week: TapImmune, CalibreScientific, Medicover Holding
US-based clinical-stage immuno-oncology company TapImmune has signed an agreement to merge with Marker Therapeutics
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox